Trial Profile
Prospective study to investigate relation between levels of caspase-cleaved cytokeratin (cCK18) and total cytokeratin (tCK18) with radiological response to chemotherapy in patients with adenocarcinoma subtype of non-small cell lung cancer (adeno-NSCLC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Biomarker; Pharmacodynamics
- 11 Dec 2015 New trial record